SABRATEK CORP
SC 13D/A, 1997-04-18
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: KNOLL INC, 8-A12B, 1997-04-18
Next: SABRATEK CORP, SC 13D/A, 1997-04-18




- -------------------------------------------------------------------------------


                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13D


                    Under the Securities Exchange Act of 1934
                               (Amendment No. 1 )*


                              Sabratek Corporation
                                (Name of Issuer)

                                  Common Stock
                         (Title of Class of Securities)

                                  78571 U 10 8
                                 (Cusip Number)

                     Doron C. Levitas, Sabratek Corporation
          5601 West Howard Street, Niles, Illinois 60174 (847) 647-2760
           (Name, Address and Telephone Number of Person Authorized to
                       Receive Notes and Communications)

                                  April 9, 1997
             (Date of Event which Requires Filing of this Statement)

   If the filing  person has  previously  filed a statement  on Schedule  13G to
   report the  acquisition  which is the subject of this  Schedule  13D,  and is
   filing this schedule  because of Rule 13d-1(b)(3) or (4), check the following
   box |_|.

   Check the following box if a fee is being paid with the statement |_|. (A fee
   is not required only if the reporting person: (1) has a previous statement on
   file reporting beneficial ownership of more than five percent of the class of
   securities  described  in Item 1; and (2) has filed no  amendment  subsequent
   thereto  reporting  beneficial  ownership  of  five  percent  or less of such
   class.) (See Rule 13d-7.)

   Note:  Six copies of  this statement, including all exhibits, should be filed
   with  the  Commission. See Rule 13a-1(a) for other parties to whom copies are
   to be sent.

   *The  remainder  of this  cover  page  shall be  filled  out for a  reporting
   person's  initial  filing on this form with  respect to the subject  class of
   securities,  and for any subsequent  amendment  containing  information which
   would alter disclosures provided in a prior cover page

   The  Information  required on the  remainder  of this cover page shall not be
   deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
   Act of 1934 ("Act") or otherwise  subject to the  liabilities of that section
   of the Aa but shall be subject to all other  provisions  of the Act (however,
   see the Notes).











- --------------------------------------------------------------------------------



<PAGE>









                                  SCHEDULE 13D
- ----------------------------------           -----------------------------------
CUSIP No. 78571 U 10 8                         Page ___2___ of ___4___ Pages
                                                               
- ----------------------------------           -----------------------------------


- --------------------------------------------------------------------------------
  1      NAME OR REPORTING PERSON
         S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON


            Doron C. Levitas S.S.N.:  ###-##-####
- --------------------------------------------------------------------------------
  2      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*


- --------------------------------------------------------------------------------
  3      SEC USE ONLY


- --------------------------------------------------------------------------------
  4      SOURCE OF FUNDS*

            00
- --------------------------------------------------------------------------------
  5      CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO 
         ITEMS 2(d) or 2(e)                                             |_|


- --------------------------------------------------------------------------------
  6      CITIZENSHIP OR PLACE OF ORGANIZATION

            The United States of America
- --------------------------------------------------------------------------------

                            7       Sole Voting Power          425,961
      NUMBER OF
       SHARES
    BENEFICIALLY
      OWNED BY
        EACH
      REPORTING
       PERSON
        WITH
                      ----------------------------------------------------------
                            8       Shared Voting Power           0
                      ----------------------------------------------------------
                            9       Sole Dispositive Power     425,961
                      ----------------------------------------------------------
                           10       Shared Dispositive Power        0

- --------------------------------------------------------------------------------
   11       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

                     425,961
- --------------------------------------------------------------------------------
   12       CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES 
            CERTAIN SHARES*                                            |_|

- --------------------------------------------------------------------------------
   13       PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

                     4.34%
- --------------------------------------------------------------------------------
   14       TYPE OF PERSON REPORTING*

                     IN
- --------------------------------------------------------------------------------
                      *SEE INSTRUCTIONS BEFORE FILLING OUT!
          INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
       (INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION




<PAGE>



                         -------------------------------------------------------
                                                               Page 3 of 4 Pages
                                                                     
                         -------------------------------------------------------



Item 1.           Security and Issuer.

   This  Amendment to Schedule  13-D,  dated April 18,  1997,  filed by Doron C.
Levitas, relates to the common stock, par value of $.01 per share (the "Sabratek
Common Stock"), of Sabratek Corporation, a Delaware corporation (the "Issuer" or
"Sabratek").  The principal  executive offices of the Issuer are located at 5601
West Howard Street,  Niles,  Illinois 60714.  All capitalized  terms used herein
shall have the definitions set forth in the Schedule, except as may otherwise be
provided herein.

Item 2.           Identity and Background.

   This  statement  is being  filed by Doron C.  Levitas,  Vice  Chairman of the
Board,  Vice President of International  Operations and Secretary and a director
of Sabratek.  His business address is 5601 West Howard Street,  Niles,  Illinois
60714.

   During  the last five  years,  Mr.  Levitas  has never  been  convicted  in a
criminal proceeding (excluding traffic violations or similar misdemeanors),  nor
has he been party to a civil proceeding of a judicial or administrative  body of
competent  jurisdiction  as a result of which Mr. Levitas was or is subject to a
judgment,  decree or final order enjoining future  violations of, or prohibiting
or mandating  activities subject to, federal or state securities laws or finding
any violation with respect to such laws.

Item 3.           Source and Amount of Funds or Other Consideration.

   Mr. Levitas acquired 391,191 shares of Sabratek Common Stock in consideration
of personal  services he rendered  during the  incorporation  of  Sabratek.  The
Options (the "Options") to purchase Sabratek Common Stock were acquired pursuant
to  Sabratek's  1993  Employee  Stock  Option  Plan (the  "Plan") and the shares
underlying  the Plan are  registered on a Form S-8  registration  statement,  of
those  shares,  34,770 are  exercisable  within 60 days.  On April 9, 1997,  Mr.
Levitas sold 24,321 share of Sabratek  Common Stock to Bear,  Stearns & Co. Inc.
as  representative  of the Underwriting  Agreement,  dated April 4, 1997, by and
among Bear,  Stearns & Co. Inc.,  Solomon  Brothers Inc.,  Smith Barney Inc, and
Jefferies  & Company,  Inc.,  as  Representatives  of the  several  Underwriters
(collectively,  the  "Underwriters")  named in Schedule I attached thereto,  the
Issuer and the Selling Stockholders named in Schedule II attached thereto. Those
shares were resold by the  Underwriters to the public pursuant to a registration
statement on Form S-1 (File No.  333-23437).  Mr.  Levitas  acquired such shares
upon exercise of a portion of the Options.



<PAGE>


                         -------------------------------------------------------
                                                               Page 4 of 4 Pages
                                                                     
                         -------------------------------------------------------


Item 4.           Purpose of Transaction.

                                                        N/A

Item 5.           Interest in Securities of the Issuer.

   As of April 18,  1997,  Mr.  Levitas is deemed to  beneficially  own  425,961
shares of Sabratek  Common Stock  (approximately  4.34% of the  Sabratek  Common
Stock outstanding),  which includes 34,770 shares subject to options exercisable
by Mr.  Levitas  within  60  days.  The  percentage  of  Sabratek  Common  Stock
outstanding  is calculated  based upon  information  contained in Post Effective
Amendment  No. 1 to the  Issuer's  Registration  Statement  on Form S-1 as filed
pursuant to the  Securities Act of 1933, as amended,  which became  effective on
April 4, 1997 (File No.  333-23437).  On April 9, 1997, Mr. Levitas ceased to be
the beneficial owner of more than five (5) percent of the class of securities of
Issuer.

Item 6.           Contracts, Arrangements, Understandings or Relationship
with Respect to Securities of the Issuer.

         NONE

Item 7.           Material to be Filed as Exhibits.

         NONE



                                    SIGNATURE

   After  reasonable  inquiry  and to the best of my  knowledge  and  belief,  I
certify that the information  set forth in this statement is true,  complete and
correct.

Dated:            April 18, 1997

                                            By:      /s/ Doron C. Levitas
                                                     Name:  Doron C. Levitas










© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission